Rebecca F. McClure

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

Animesh Pardanani, Ross L. Levine, Terra L. Lasho et al. · Blood · 2006 · 1K citations · Full text

Life Sciences, Genetics, Hematology +14

Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

Ken‐Hong Lim, Ayalew Tefferi, Terra L. Lasho et al. · Blood · 2009 · 574 citations

Life Sciences, Immunology, Internal Medicine +7

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both “atypical” myeloproliferative disorders and myelodysplastic syndromes

David P. Steensma, Gordon W. Dewald, Terra L. Lasho et al. · Blood · 2005 · 466 citations · Full text

Medicine, Genetics, Hematology +8

Essential Thrombocythemia Beyond the First Decade: Life Expectancy, Long-term Complication Rates, and Prognostic Factors

Alexandra P. Wolanskyj, Susan M. Schwager, Rebecca F. McClure et al. · Mayo Clinic Proceedings · 2006 · 325 citations

Medicine, Hematology, Internal Medicine +13

IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis

Ayalew Tefferi, Terra L. Lasho, Omar Abdel‐Wahab et al. · Leukemia · 2010 · 312 citations · Full text

Medicine, Genetics, Hematology +11